Abstract
Colorectal cancer is the third most deadly cancer globally. Drug resistance and attendant side effects make the available standard anti-colorectal cancer drugs against target receptors inefficient. Phytochemicals from medicinal plants are safer, cheaper, effective, and heal diseases from the cellular level. This study is aimed at identifying potential inhibitors of thymidylate synthase (TS) and nuclear factor kappa-B (NF–κB) target receptors from Capsicum annuum towards the development of new therapeutic drugs against colorectal cancer via in silico approach. One hundred and fifty (150) ligands previously reported from Capsicum annuum were downloaded from the PubChem database and were subjected to chemo-informatics analyses such as ADMET, drug-likeness, oral bioavailability, bioactivity, and PASS prediction to ascertain their therapeutic and safety profile before docking. The ligands that passed the analyses were docked against TS and NF–κB in duplicate using a creditable docking tool (PyRx). Raltitrexed and emetine were used as the standard drug inhibitors for TS and NF–κB, respectively. The results obtained from this study showed that feruloyl-beta-D-glucose (8.45 kcal/mol), 5-O-caffeoylquinic acid (−8.40 kcal/mol), 5-O-caffeoylquinic acid methyl ester (−7.89 kcal/mol), feruloyl hexoside (−7.40 kcal/mol), O-glucopyranoside (−7.55 kcal/mol), and quercetin (−7.00 kcal/mol) shared the same binding pocket with TS while feruloyl-beta-D-glucose (−7.00 kcal/mol), chlorogenic acid (−6.90 kcal/mol), 5-O-caffeoylquinic acid (−6.90 kcal/mol) and feruloyl hexoside (−6.50 kcal/mol) shared the same pocket with NF–κB. These compounds were selected as best hits due to their excellent inhibitory efficiency and chemoinformatic profiles. Thus, the compounds may function as prospective lead compounds for developing a new anti-colorectal cancer drug.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: None declared.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. World, Health Statistics. Monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2019.Search in Google Scholar
2. Parkin, DM, Hammer, L, Ferlay, J, Kantelhardt, EJ. Cancer in Africa 2018: the role of infections. Int J Cancer 2019;146:2089–103. https://doi.org/10.1002/ijc.32538.Search in Google Scholar PubMed
3. Azubuike, SO, Muirhead, C, Hayes, L, McNally, R. Rising global burden of breast cancer: the case of Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review. World J Surg Oncol 2018;16:63. https://doi.org/10.1186/s12957-018-1345-2.Search in Google Scholar PubMed PubMed Central
4. McCullough, ML, Zoltick, ES, Weinstein, SJ, Fedirko, V, Wang, M, Cook, NR, et al.. Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts. J Natl Cancer Inst 2019;2:158–69. https://doi.org/10.1093/jnci/djy087.Search in Google Scholar PubMed PubMed Central
5. Yang, T, Li, X, Farrington, SM, Dunlop, MG, Campbell, H, Timofeeva, M, et al.. Systematic analysis of interactions between environmental risk factors and genetic variation in susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 2020;29:1145–53. https://doi.org/10.1158/1055-9965.epi-19-1328.Search in Google Scholar PubMed PubMed Central
6. Bray, F, Ferlay, J, Soerjomataram, I, Siegel, RL, Torre, LA, Jemal, A. Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 2018;68:394–424. https://doi.org/10.3322/caac.21492.Search in Google Scholar PubMed
7. American Cancer Society. Cancer facts & figures. Atlanta, Ga: American Cancer Society; 2022.Search in Google Scholar
8. Siegel, RL, Miller, KD, Jemal, A, Cancer statistics. CA A Cancer J Clin 2018;68:7–30. https://doi.org/10.3322/caac.21442.Search in Google Scholar PubMed
9. Yang, P, Liu, W, Fu, R, Ding, GB, Amin, S, Li, Z. Cucurbitacin E chemosensitizes colorectal cancer cells via mitigating TFAP4/wnt/β-catenin signaling. J Agric Food Chem 2020;68:14148–160. https://doi.org/10.1021/acs.jafc.0c05551.Search in Google Scholar PubMed
10. Xie, YH, Chen, YX, Fang, JY. A comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Targeted Ther 2020;5:1–30.10.1038/s41392-020-0116-zSearch in Google Scholar PubMed PubMed Central
11. Longley, DB, Harkin, DP, Johnston, PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330–8. https://doi.org/10.1038/nrc1074.Search in Google Scholar PubMed
12. Chen, W, Dong, J, Haiech, J, Kilhoffer, MC, Zeniou, M. Cancer stem cell quiescence and plasticity as major challenges in cancer therapy. Stem Cell Int 2016;2016:1–16. https://doi.org/10.1155/2016/1740936.Search in Google Scholar PubMed PubMed Central
13. Sakatani, A, Sonohara, F, Goel, A. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells. Carcinogenesis 2019;40:422–31. https://doi.org/10.1093/carcin/bgy186.Search in Google Scholar PubMed PubMed Central
14. Soleimani, A, Rahmani, F, Ferns, G, Ryzhikov, M, Avan, A, Hassanian, SM. Role of the NF-κB signalling pathway in the pathogenesis of colorectal cancer. Gene 2019;726:144132. https://doi.org/10.1016/j.gene.2019.144132.Search in Google Scholar PubMed
15. Brenner, H, Kloor, M, Pox, CP. Colorectal cancer. Lancet 2014;383:1490–502. https://doi.org/10.1016/s0140-6736(13)61649-9.Search in Google Scholar
16. Vaghari-Tabari, M, Majidinia, M, Moein, S, Qujeq, D, Asemi, Z, Alemi, F, et al.. MicroRNAs and colorectal cancer chemoresistance: new solution for old problem. Life Sci 2020;259:118255. https://doi.org/10.1016/j.lfs.2020.118255.Search in Google Scholar PubMed
17. McManus, KD. What is a plant-based diet and why should you try it?; 2018. Available from: https://www.health.harvard.edu/blog/what-is-aplant-based-diet-and-why-should-you-try-it2018092614760 [Accessed 7 Apr 2022].Search in Google Scholar
18. Francenia, SN, Salas-Coronado, R, Hernández, CB, Villanueva-Cañongo, C. Shikimic acid pathway in biosynthesis of phenolic compounds. In: Soto-Hernández, M, editor. Plant physiological aspects of phenolic compounds. London, UK: Intech Open; 2019.Search in Google Scholar
19. Chang, H, Lei, L, Zhou, Y, Ye, F, Zhao, G. Dietary flavonoids and the risk of colorectal cancer: an updated meta-analysis of epidemiological studies. Nutrients 2018;10:950. https://doi.org/10.3390/nu10070950.Search in Google Scholar PubMed PubMed Central
20. Benarba, B, Pandiella, A. Colorectal cancer and medicinal plants: principle findings from recent studies. Biomed Pharma 2018;107:408–23. https://doi.org/10.1016/j.biopha.2018.08.006.Search in Google Scholar PubMed
21. Clement, KC, Coulibaly, B, Ibourahema, C, Carole, KA, Rose, KN. Antimicrobial activity of the varieties of peppers (Capsicum) of côte d’Ivoire on multiresistant strains. Int J Curr Microbiol Appl Sci 2016;5:875–90. https://doi.org/10.20546/ijcmas.2016.510.096.Search in Google Scholar
22. Wesolowska, A, Grzeszczuk, M, Jadczak, D. GC-MS analysis of essential oils isolated from fruits of chosen hot pepper (Capsicum annuum L.) cultivars. Folia Pomer Univ Technol Stetin Agric Aliment Pics Zootech 2015;3:95–108.Search in Google Scholar
23. Talevi, A. Computer-aided drug design: an overview. Comput Drug Dis Design 2018;1762:1–19.10.1007/978-1-4939-7756-7_1Search in Google Scholar PubMed
24. Huang, M, Yang, Y, Zhu, X, Chen, Z, Zhang, W, Wang, C, et al.. A prospective phase II study of raltitrexed combined with S-1 as salvage treatment for patients with refractory metastatic colorectal cancer. Asia Pac J Clin Oncol 2021;17:513–21.10.1111/ajco.13511Search in Google Scholar PubMed PubMed Central
25. Ramachandran, GT, Sasisekharan, V. Conformation of polypeptides and proteins. Adv Protein Chem 1968;23:283–437. https://doi.org/10.1016/s0065-3233(08)60402-7.Search in Google Scholar PubMed
26. BIOVIA, DS. Discovery studio visualizer. San Diego; 2019.Search in Google Scholar
27. Tian, W, Chen, C, Lei, X, Zhao, J, Liang, J. CASTp 3.0: computed Atlas of surface Topography of proteins. Nucleic Acids Res 2018;46:W363–7. https://doi.org/10.1093/nar/gky473.Search in Google Scholar PubMed PubMed Central
28. Hongbin, Y, Chaofeng, L, Lixia, S, Jie, L, Yingchun, C, Zhuang, W, et al.. admetSAR 2.0: web service for prediction and optimization of chemical ADMET properties. Bioinformatics 2018;35:1067–9. https://doi.org/10.1093/bioinformatics/bty707.Search in Google Scholar PubMed
29. Lipinski, CA. Lead and drug-like compounds: the rule of five revolutions. Drug Discov Today Technol 2004;1:337–41.10.1016/j.ddtec.2004.11.007Search in Google Scholar PubMed
30. Lipinski, CA, Lombardo, F, Dominy, BW, Feeney, PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development. Adv Drug Deliv Rev 2021;46:3–25.10.1016/S0169-409X(00)00129-0Search in Google Scholar PubMed
31. Daina, A, Michielin, O, Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717. https://doi.org/10.1038/srep42717.Search in Google Scholar PubMed PubMed Central
32. Chen, D, Jansson, A, Sim, D, Larsson, A, Nordlund, P. Structural analyses of human thymidylate synthase reveal a site that may control signal switching between active and inactive states. J Biol Chem 2017;292:13449–58. https://doi.org/10.1074/jbc.m117.787267.Search in Google Scholar
33. Cramer, P, Larson, JC, Verdine, LG, Muller, WC. Structure of the human NF-kB p52 homodimer-DNA complex at 2.1 resolution. EMBO J 1997;16:7078–90. https://doi.org/10.1093/emboj/16.23.7078.Search in Google Scholar PubMed PubMed Central
34. Viennois, E, Chen, F, Merlin, D. (2012). NF-kB pathway in colitis-associated cancers, Transl Gastrointest Cancer 2012; 2:21–9. https://doi.org/10.3978/j.issn.2224-4778.2012.11.01.Search in Google Scholar PubMed PubMed Central
35. Soleimani, A, Rahmani, F, Ferns, AG, Ryzhikov, M, Avan, A, Hassanian, MS. Role of the NF-kB signalling pathway in the pathogenesis of colorectal cancer. Gene 2020;726:144132.10.1016/j.gene.2019.144132Search in Google Scholar PubMed
36. Wang, F, Wu, FX, Li, CZ, Jia, CY, Su, SW, Hao, GF, et al.. ACID: a free tool for drug repurposing using consensus inverse docking strategy. J Chemoinf 2019;11:1–11. https://doi.org/10.1186/s13321-019-0394-z.Search in Google Scholar PubMed PubMed Central
37. Kar, S, Sepulveda, MS, Roy, K, Leszczynski, J. The endocrine-disrupting activity of per- and polyfluoroalkyl substances: exploring combined approaches of ligand and structure-based modelling. Chemosphere 2017;184:414–523.10.1016/j.chemosphere.2017.06.024Search in Google Scholar PubMed
38. Macalino, SJY, Gosu, V, Hong, S, Choi, S. Role of computer-aided drug design in modern drug discovery. Arch Pharm Res 2015;38:1686–701. https://doi.org/10.1007/s12272-015-0640-5.Search in Google Scholar PubMed
39. Wu, W, Sanguinetti, MC. Molecular basis of cardiac delayed rectifier potassium channel function and pharmacology. Card Electrophysiol Clin 2016;8:275–84. https://doi.org/10.1016/j.ccep.2016.01.002.Search in Google Scholar PubMed PubMed Central
40. Tsaioun, K, Kates, SA. ADMET for medicinal chemists: a practical guide. New York: John Wiley & Sons; 2011.10.1002/9780470915110Search in Google Scholar
41. Sander, T. OSIRIS property explorer. 2001 organic chemistry portal. Available from: https://www.organic-chemistry.org/prog/peo.10.1002/1099-0690(200110)2001:20<3771::AID-EJOC3771>3.0.CO;2-0Search in Google Scholar
42. López-vallejo, F, Caulfield, T, Martínez-Mayorga, K, Giulianotti, MA, Nefzi, A, Houghten, RA, et al.. Integrating virtual screening and combinatorial chemistry for accelerated drug discovery. Comb Chem High Throughput Screen 2011;14:475–87. https://doi.org/10.2174/138620711795767866.Search in Google Scholar
43. Ferreira, LG, Santos, RN, Oliva, G, Andricopulo, AD. Molecular docking and structure-based drug design strategies. Molecules 2015;20:13384–421. https://doi.org/10.3390/molecules200713384.Search in Google Scholar
44. Adeoye, AO, Olanlokun, JO, Tijani, H, Lawal, SO, Babarinde, CO, Akinwole, MT, et al.. Molecular docking analysis of apigenin and quercetin from ethyl acetate fraction of adansonia digitata with malaria-associated calcium transport protein: an in silico approach. Heliyon 2019;5:e02248. https://doi.org/10.1016/j.heliyon.2019.e02248.Search in Google Scholar
45. Oso, BJ, Olaoye, IF. Comparative in vitro studies of antiglycemic potentials and molecular docking of Ageratum conyzoides L. and Phyllanthus amarus L. methanolic extracts. SN Appl Sci 2020;2:629. https://doi.org/10.1007/s42452-020-2275-5.Search in Google Scholar
46. Hughes, JP, Rees, S, Kalindjian, SB, Philpott, KL. Principles of early drug discovery. Br J Pharmacol 2011;162:1239–49. https://doi.org/10.1111/j.1476-5381.2010.01127.x.Search in Google Scholar
47. Stevens, E. Lead discovery. In: Jaworski, A, editor. Medicinal chemistry: modern drug discovery process. New Jersey: Pearson; 2014:247–72 pp.Search in Google Scholar
48. Schultes, S, Kooistra, A, Vischer, HF, Nijmeijer, S, Haaksma, EE, Leurs, R, et al.. Combinatorial consensus scoring for ligand-based virtual fragment screening: a comparative case study for serotonin 5-HT 3 A, histamine H 1 and histamine H 4 receptors. J Chem Inf Model 2015;55:1030–44. https://doi.org/10.1021/ci500694c.Search in Google Scholar PubMed
49. Burlingham, BT, Widlanski, TS. An intuitive look at the relationship of Ki and IC50: a more general use for the dixon plot. J Chem Educ 2003;80:214–8. https://doi.org/10.1021/ed080p214.Search in Google Scholar
50. Nisha, CM, Kumar, A, Gupta, N, Silakari, C, Tripathi, T, Kumar, A. Molecular docking and in silico ADMET study reveals acylguanidine 7a as a potential inhibitor of β-secretase. Adv Bioinform 2016;2016:9258578.10.1155/2016/9258578Search in Google Scholar PubMed PubMed Central
51. Schultes, S, De Graaf, C, Haaksma, EEJ, De Esch, IJP, Leurs, R, Kramer, O. Ligand efficiency as a guide in fragment hit selection and optimization. Drug Discov Today Technol 2010;7:e157–62. https://doi.org/10.1016/j.ddtec.2010.11.003.Search in Google Scholar PubMed
52. Hopkins, AL, Keserü, GM, Leeson, PD, Rees, DC, Reynolds, CH. The role of ligand efficiency metrics in drug discovery. Nat Rev Drug Discov 2014;13:105–21. https://doi.org/10.1038/nrd4163.Search in Google Scholar PubMed
53. Filimonov, DA, Lagunin, AA, Gloriozova, TA, Rudik, AV, Druzhilovskii, DS, Pogodin, PV, et al.. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Compd 2014;50:444–57. https://doi.org/10.1007/s10593-014-1496-1.Search in Google Scholar
© 2023 Walter de Gruyter GmbH, Berlin/Boston
